Conf Banner

RGCON 2025

Dear esteemed participants,

On behalf of the organising committee, it gives me immense pleasure to extend a warm welcome to you all to the 23rd Annual International Conference organised by Rajiv Gandhi Cancer Institute & Research Centre- “RGCON 2025” which is scheduled to take place from 21st – 23rd March at Hotel Crowne Plaza, Rohini, New Delhi, India.

The conference theme for this year is “Gynecological Cancers: Innovating, Integrating and Updating.” RGCON 2025 promises an enriching experience, with a compelling programme featuring the latest groundbreaking advancements and research in the field of Gynecological oncology, complemented by vibrant networking events.

We have curated comprehensive sessions with an impressive lineup of esteemed renowned national and international speakers, deeply wishing that this event promises to be a dynamic and enriching experience for all attendees.

We invite clinicians, researchers, students, and all healthcare professionals with an interest in Gynae-oncology to join us for this remarkable event. Together, let’s elevate the standard of care, improve patient outcomes, and make a significant impact on the fight against Gynecological cancers.

Warm Regards,
Dr. Vandana Jain
Organizing Secretary

Hotel Crowne Plaza, Rohini 21st Mar - 20th Mar, 2025

ORGANIZING COMMITTEE

PATRONS
Mr. Rakesh Chopra

Chairman

Mr. D. S. Negi

Chief Executive Officer

Dr. D C Doval

Chair Medical Oncology & Chief of Breast & Thoracic Services

Dr. A K Dewan

Director Surgical Oncology

Dr. Anurag Mehta

Director – Department of Laboratory & Transfusion Services and Director Research

ORGANIZING CHAIRMAN
Dr. Sudhir Rawal

Medical Director

ORGANIZING SECRETARY
Dr. Vandana Jain

Head Gynae Oncology

CO-ORGANIZING SECRETARY
Dr. Ullas Batra

Co -Director Med Oncology and Chief of Thoracic Medical Oncology

Dr. Sumit Goyal

Senior Consultant, Dept. of Medical Oncology

Dr. Anjali K Pahuja

Senior Consultant- Department of Radiation Oncology

Dr. Anila Sharma

Senior Consultant – Histopathology

Dr. Sarika Gupta

Sr. Consultant & Unit Head – Gynae Surgical Oncology (Unit – II)

Faculty

International Faculty
Dr. Baljeet Kaur

Consultant Cellular Pathologist, Regional Lead for Gestational Trophoblast pathology(GTD) and Malignant Ovarian Germ Cell (MOGCT) servicevice, Imperial College Healthcare NHS Trust, London, UK

Dr. Ben Davidson

Senior Pathologist, Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital; Professor, Faculty of Medicine, University of Oslo, Norway

Dr. Christina Fotopoulou

Consultant gynaecological oncologist at Queen Charlotte's & Chelsea Hospital. She was trained in obstetrics and gynaecology at the Charité University Hospital of Berlin with a sub-specialism in gynaecological oncology, Germany

Dr. Denis Querleu

Former president of the European Society of Gynecological Oncology, a visiting professor at Rome’s Gemelli University Hospital, and a consultant at Strasbourg’s IHU, France

Dr. Dennis S. CHI

Chair in Gynecologic Surgery, Deputy Chief of the Gynecology Service, and Head of Ovarian Cancer Surgery at Memorial Sloan Kettering Cancer Center, New York, USA

Dr. Henrik Falconer

Head of Gynecologic Oncology at Karolinska University Hospital and Associate Professor at Karolinska Institute, Sweden

Dr. Jalid Sehouli

Medical Director, Department of Gynecology including center of oncological surgery (CVK) and Department of Gynaecology (CBF), Berlin, Germany

Dr. Jonathan Ledermann

Professor of Medical Oncology and Clinical Director at UCL Cancer Institute, University College London, and a Consultant Medical Oncologist at UCL Hospitals, London

Dr. K. Rainer Kimmig

Chair for Gynecology and Obstetrics at the University of Essen Director of the Clinic for Gynecology and Obstetrics at the University of Essen, Germany

Dr. Mario Leitao

Attending Surgeon & Member, Division of Gynecology/Professor, Weill Cornell Medical College/Director, Gynecologic Oncology Fellowship Program/Director, Minimal Access and Robotic Surgery (MARS)/ Program, Department of Surgery Memorial Sloan-Kettering Cancer Center, New York, USA

Dr. Mustafa Zelal Muallem

Professor for gynecological oncology and oncological surgery. Deputy Director of Department of Gynecology with Center for Oncological Surgery Charité Medical University of Berlin, Germany

Dr. Neville Hacker

Founder and Director of AGCF (Australian Gynaecological Cancer Foundation), Professor of Gynecological Oncology, Conjoint, at the University of NSW, Australia

Dr. Nicolo Bizzarri

ENYGO Past President, IJGC Editorial Board, Gynecologic Oncology Unit, Catholic University of the Sacred Heart Policlinico Agostino Gemelli IRCCS Largo A. Gemelli, Rome (Italy)

Dr. Peter Lim

Medical Director of Gynecologic Oncology and Robotic Surgery at Center of Hope and Clinical Associate Professor of Obstetrics and Gynecology at the University of Nevada Reno School of Medicine, USA

Dr. Walter Gotlieb

Academic chief at Allegheny health network and a professor of radiation oncology at Drexel University, USA

Dr. Sushil Beriwal

Professor, Department of Obstetrics and Gynecology, Department of Oncology, Director of Surgical Oncology, McGill University, Canada

ABSTRACT SUBMISSION

GENERAL GUIDELINES FOR SUBMISSION:
  • Abstracts must be original and must not be or have been published or presented at any other meeting prior to the 23rd RGCON 2025, New Delhi.
  • Abstracts must be submitted online via the website and indicate whether the abstract is for Oral Presentation, e-Poster Presentation & Video Presentation.
  • Only the presenting author can be submit an abstract
  • Abstracts must be received by the announced deadline.
  • The Scientific Committee of RGCON 2025 will determine whether the abstract is accepted as an oral presentation or a poster presentation, with consideration given to the author’s preference.
  • Ethical considerations: For clinical trials, details of ethical committee approval and types of informed consent should be stated. Names and initials of patients or volunteers should not be used.
  • In order to submit an abstract, all presenters are required to pay the full registration fees before submitting an abstract.
  • For any further information related to abstract submission, please contact Secretariat by e-mail rgcon2025@gmail.com
  • Capitalize the first letter of all words in your title. However, do not capitalize article words such as "a", "the", "and" & "of" unless the article is the first word of the title.
  • All abstracts must contain the following information: Introduction, Materials & Methods, Results and Conclusion.
  • Abstracts should be no more than 250 words. Tables or figures are not allowed.
ABSTRACT ACCEPTANCE:
  • The Scientific Committee of RGCON 2025 reserves the rights to make the final decision of presentation categories and acceptance/rejection of abstract.
  • Authors will be notified by email no later than 10th February 2025 about the acceptance/ rejection of their abstracts and the category of the presentation (Paper/ e-Poster)
PRESENTATION TIME:
  • Oral presentation: 6-min each, followed by 2 minute discussion
  • e-Poster presentation: Will be form of the e posters and they will be displayed through out the conference. Best 15 e-posters will be physically presented by the author.
  • Video presentation: Step 1 - Length of the surgical videos should be 6 minutes. Only .mp4 formats will be accepted. Only HD videos will qualify for submission: 1280 X 720 (720p). Image quality should be suitable for large auditorium screening.
  • Video presentation: Step 2 - Videos should be narrated in English language only, clearly done with no music, using high-quality audio recording. Computer-generated narrations will not qualify for submission.
  • Video presentation: Step 3 - Kindly add subtitles, if relevant.
SUBMISSION TOPICS/ABSTRACT CATEGORY
  • Cervical Cancer
  • Endometrial Cancer
  • Ovarian Cancer
  • Vaginal and Vulvar Cancer
  • Trophoblastic Diseases
  • Other rare gynecological cancers
  • Palliative Care & Quality of Life after Treatment of Gynecologic Cancer
  • Non-invasive disease of Gynecologic Cancer (pre-cancer)
  • Translational Research, Basic science& Novel therapy (ADC, cell therapy...)
  • Surgical techniques (minimally invasive surgery, new method, HIPEC...)
  • Immunotherapy and relevant topics
  • Genomic, biomarker or prognostic marker
  • Artificial intelligence(AI), database
  • Imaging
ABSTRACT SUBMISSION DEADLINE:
  • 31st December 2024

CONTACT DETAILS

For any further query, please contact:
Ms Ruchi Balodi
M. +91 95998 19331
E. rgcon2025@gmail.com

For any query about Sponsorship, please contact:
Ms. Anju Chauhan
M. +91 98731 55130
E. rgcon2025@gmail.com

For Any query about Scientific Program, please contact:
Dr. Vandana Jain
M. +91 99107 00788
E. rgcon2025@gmail.com

Opportunity to Help

DONATE FOR CANCER CARE

As a society, RGCIRC is looking forward to get support from generous people

Read More
DONATE BLOOD

It is a fact that there are absolutely no substitutes to replace human bloo...

Read More
DONATE TIME (VOLUNTEER)

Volunteers play an important role in today’s hospitals. They help the hos...

Read More

Rajiv Gandhi Cancer Institute & Research Centre is today counted amongst Asia’s premier exclusive cancer centres that offer unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others.

D - 18, Sector - 5, Rohini, Delhi - 110085 | +91-11-47022222
OPD Timings: 09:00 am to 05:00 pm (All weekdays except Sunday and Holiday)
Emergency Services: 24x7 All weekdays

Mahendra Kumar Jain Marg, Niti Bagh, New Delhi - 110049 | Tel: +91-11-45822222 / 2200
OPD Timings: 09:00 am to 05:00 pm (All Weekdays except Sunday and Holiday)
Emergency Services: 24x7 All Weekdays

Subscribe Today For Our Healthy Tips Newsletter
Loading